title: Hysteropexy: Evidence and Insights.
abstract: Uterovaginal prolapse may be treated with or without concomitant hysterectomy. Many patients express interest in uterine-sparing prolapse procedures, for which there are increasing evidence available regarding techniques and outcomes. Uterine-sparing procedures to treat uterovaginal prolapse require a unique set of surgical considerations including uterine abnormalities, possibility of occult malignancy, and future pregnancy. Data, including randomized controlled trials, support the use of sacrospinous hysteropexy. Other prospective trials detailing outcomes following uterosacral hysteropexy, mesh augmented sacrospinous hysteropexy, and sacrohysteropexy are also encouraging.
authors.affiliation: *Women's Health Institute, Cleveland Clinic, Cleveland, Ohio †Providence Saint John's Health Center, Santa Monica, California.
authors.forename: Beri M
authors.initials: BM
authors.lastname: Ridgeway
authors.forename: Lauren
authors.initials: L
authors.lastname: Cadish
mesh_terms: D005260:Female; D013509:Gynecologic Surgical Procedures / Q000379:methods*; D006801:Humans; D007044:Hysterectomy; D059351:Organ Sparing Treatments; D011247:Pregnancy; D016896:Treatment Outcome; D014596:Uterine Prolapse / Q000601:surgery*; D014599:Uterus / Q000601:surgery*; D014621:Vagina / Q000601:surgery*